From 42999857af48e48e1608fd25ac0218fc2f750ca1 Mon Sep 17 00:00:00 2001 From: "github-actions[bot]" Date: Sat, 4 Apr 2026 13:37:06 +0000 Subject: [PATCH] chore: update performance tracking 2026-04-04 --- .../recommendations/performance_database.json | 82 ++++++++++++++++++- data/recommendations/statistics.json | 6 +- 2 files changed, 83 insertions(+), 5 deletions(-) diff --git a/data/recommendations/performance_database.json b/data/recommendations/performance_database.json index 32378817..90227484 100644 --- a/data/recommendations/performance_database.json +++ b/data/recommendations/performance_database.json @@ -1,6 +1,6 @@ { - "last_updated": "2026-04-04 13:34:53", - "total_recommendations": 561, + "last_updated": "2026-04-04 13:37:06", + "total_recommendations": 565, "recommendations_by_date": { "2026-02-10": [ { @@ -13118,6 +13118,84 @@ "return_1d": 0.0, "win_1d": false } + ], + "2026-04-04": [ + { + "ticker": "PAGS", + "rank": 1, + "company_name": "PagSeguro Digital Ltd.", + "description": "PagSeguro Digital Ltd. engages in the provision of financial and payment solutions for consumers, entrepreneurs, and small/medium businesses in Brazil.", + "strategy_match": "insider_buying", + "pipeline": "insider_buying", + "final_score": 88, + "confidence": 8, + "risk_level": "moderate", + "reason": "Director Luis Frias executed a massive $4.96M insider purchase, providing a strong fundamental floor for the stock. This is corroborated by highly unusual bullish options flow, highlighted by a staggering 0.021 P/C ratio and heavy call buying at the $14 strike. Technicals are aligning with the accumulation, showing a MACD bullish crossover and price action holding above the 20 EMA and VWAP. The risk/reward is highly favorable given the low valuation (P/E 7.55), though failure to break the 50 SMA at $10.51 could stall momentum.", + "entry_price": 10.34000015258789, + "discovery_date": "2026-04-04", + "status": "open", + "current_price": 10.34000015258789, + "return_pct": 0.0, + "days_held": 0, + "last_updated": "2026-04-04" + }, + { + "ticker": "ZBIO", + "rank": 2, + "company_name": "Zenas BioPharma, Inc.", + "description": "Zenas BioPharma, Inc. is a clinical-stage biopharma company developing immunology-based therapies.", + "strategy_match": "insider_buying", + "pipeline": "insider_buying", + "final_score": 85, + "confidence": 7, + "risk_level": "high", + "reason": "ZBIO is experiencing aggressive cluster buying, with three insiders\u2014including the CEO ($1.0M) and a 10% owner ($3.0M)\u2014purchasing over $5.5M in shares. This heavy insider accumulation is a massive vote of confidence and directly challenges the elevated short interest of 21.1%. Short-term momentum is accelerating, evidenced by an intraday jump of +6.4% and the price crossing above both the VWAP and 20 EMA. While the setup is primed for a squeeze, the stock's pre-revenue status and high volatility (ATR 9.1%) present substantial fundamental risks.", + "entry_price": 21.459999084472656, + "discovery_date": "2026-04-04", + "status": "open", + "current_price": 21.459999084472656, + "return_pct": 0.0, + "days_held": 0, + "last_updated": "2026-04-04" + }, + { + "ticker": "PACB", + "rank": 3, + "company_name": "Pacific Biosciences of California, Inc.", + "description": "Pacific Biosciences of California, Inc. designs and manufactures sequencing solutions to resolve genetically complex problems.", + "strategy_match": "earnings_play", + "pipeline": "earnings_play", + "final_score": 70, + "confidence": 6, + "risk_level": "speculative", + "reason": "PACB presents a compelling binary setup heading into its earnings report in three days. The options market is aggressively positioning for an upside move, reflected by an extremely bullish P/C volume ratio of 0.086. Combined with a high short interest of 15.6%, any positive surprise or forward guidance could trigger a violent short squeeze. A recent MACD bullish crossover and an intraday bounce of +3.9% indicate pre-earnings accumulation, though the underlying cash burn and strong macro downtrend pose severe risks if earnings disappoint.", + "entry_price": 1.340000033378601, + "discovery_date": "2026-04-04", + "status": "open", + "current_price": 1.340000033378601, + "return_pct": 0.0, + "days_held": 0, + "last_updated": "2026-04-04" + }, + { + "ticker": "NNOX", + "rank": 4, + "company_name": "Nano-X Imaging Ltd.", + "description": "Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source and provides teleradiology services.", + "strategy_match": "earnings_play", + "pipeline": "earnings_play", + "final_score": 60, + "confidence": 5, + "risk_level": "speculative", + "reason": "With earnings arriving in just two days, NNOX is flashing contrarian bullish signals driven by options flow and short positioning. The options P/C ratio sits at a heavily skewed 0.241, suggesting speculators are betting on an earnings beat or short squeeze. A short interest of 13.3% provides the fuel for a potential rapid upward rerating. However, the company's operating margin of -413% and high volatility (ATR 6.3%) make this a strictly speculative, binary trade heavily reliant on the upcoming catalyst.", + "entry_price": 2.4100000858306885, + "discovery_date": "2026-04-04", + "status": "open", + "current_price": 2.4100000858306885, + "return_pct": 0.0, + "days_held": 0, + "last_updated": "2026-04-04" + } ] } } \ No newline at end of file diff --git a/data/recommendations/statistics.json b/data/recommendations/statistics.json index 61557faf..2eae88de 100644 --- a/data/recommendations/statistics.json +++ b/data/recommendations/statistics.json @@ -1,5 +1,5 @@ { - "total_recommendations": 561, + "total_recommendations": 565, "by_strategy": { "momentum": { "count": 136, @@ -32,7 +32,7 @@ "win_rate_30d": 35.7 }, "insider_buying": { - "count": 163, + "count": 165, "wins_1d": 61, "losses_1d": 101, "wins_7d": 71, @@ -62,7 +62,7 @@ "win_rate_30d": 30.0 }, "earnings_play": { - "count": 57, + "count": 59, "wins_1d": 20, "losses_1d": 37, "wins_7d": 22,